发明名称 Formulation for topical non-invasive application in vivo
摘要 A formulation comprising molecular arrangements capable of penetrating pores in a barrier, owing to penetrant adaptability, despite the fact that the average diameter of said pores is smaller than the average penetrant diameter, provided that the penetrants can transport agents or else enable agent permeation through the pores after penetrants have entered pores, characterized in that the formulation comprises at least one consistency builder in an amount that increases the formulation to maximally 5 Nm/s so that spreading over, and retention at, the application area is enabled and/or at least one antioxidant in an amount that reduces the increase of oxidation index to less than 100% per 6 months and/or at least one microbicide in an amount that reduces the bacterial count of 1 million germs added per g of total mass of the formulation to less than 100 in the case of aerobic bacteria, to less than 10 in the case of entero-bacteria, and to less than 1 in the case of Pseudomonas aeruginosa or Staphilococcus aureus, after a period of 4 days.
申请公布号 US7175850(B2) 申请公布日期 2007.02.13
申请号 US20010887493 申请日期 2001.06.22
申请人 IDEA AG 发明人 CEVC GREGOR
分类号 A61K8/02;A61K9/10;A61K9/127;A61K31/16;A61K31/56;A61K31/57;A61K31/58;A61K47/02;A61K47/10;A61K47/12;A61K47/14;A61K47/18;A61K47/20;A61K47/22;A61K47/24;A61K47/26;A61K47/28;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61K47/46;A61P1/16;A61P1/18;A61P7/06;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P17/14;A61P19/00;A61P19/02;A61P21/00;A61P25/08;A61P27/00;A61P27/02;A61P29/00;A61P31/12;A61P31/22 主分类号 A61K8/02
代理机构 代理人
主权项
地址
您可能感兴趣的专利